Neovascular macular degeneration is multifactorial, which requires future agents to target multiple pathways.
Sean D. Adrean, MD, FAAO
Advertisement
Articles by Sean D. Adrean, MD, FAAO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Timely interventions can protect vision in patients with GA
2
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
3
Enhancing Durability and Fluid Control with Aflibercept 8 mg in Retinal Vascular Diseases
4
Monitoring MacTel: Why BCVA does not tell the whole story
5
